This article is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any health or wellness routine.
Can You Lose Muscle on GLP-1s? Here's What the Research Says
If you're on Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro, Zepbound) - or thinking about starting one - you've probably heard some version of the warning: "you'll lose muscle, not just fat." It's a fair concern, and it's one worth understanding clearly rather than dismissing or fearing. Here's what the research actually shows, and what you can do about it.
What Are GLP-1 Medications?
GLP-1 receptor agonists (semaglutide, sold as Ozempic and Wegovy) and dual GLP-1/GIP receptor agonists (tirzepatide, sold as Mounjaro and Zepbound) work by mimicking a gut hormone that regulates appetite, slows digestion, and improves insulin sensitivity. Clinical trials have demonstrated substantial weight loss, with results varying by medication, dose, and patient factors. The magnitude of these results represents a major shift in medical weight management.
That effectiveness is exactly why the muscle question matters. When weight loss is this substantial, what makes up that weight loss becomes a real clinical consideration.
Do People Lose Muscle While Losing Weight on GLP-1s?
Yes, to a degree, and it's more nuanced than a headline. Body composition sub-studies from the major GLP-1 trials give us real numbers:
Body-composition analyses from semaglutide trials have similarly shown that a portion of weight lost comes from lean mass, which is consistent with what is observed during most significant weight-loss interventions.
In the SURMOUNT-1 body-composition substudy, approximately 25–26% of weight lost with tirzepatide was lean mass, while roughly 74–75% was fat mass.
A 2024 systematic review and network meta-analysis across 22 randomized trials found lean mass loss comprising approximately 25% of total weight loss on average, and importantly, found that the relative proportion of lean mass to total body weight was largely unaffected, meaning the proportion of lean mass relative to total body weight generally remained stable despite weight loss.
Here's the context that matters: lean mass loss is not unique to GLP-1 medications. Any method of substantial weight loss, including caloric restriction, bariatric surgery, and intensive lifestyle interventions, typically results in some loss of lean mass alongside fat loss. The absolute numbers can appear larger with semaglutide and tirzepatide because the overall weight loss is often much greater. This is a known and expected physiological response to significant weight loss, not a unique side effect of these medications.
Why Muscle Matters: Beyond Aesthetics
Muscle isn't just about how you look. It's central to:
Metabolic health - muscle tissue is metabolically active and helps regulate blood sugar and insulin sensitivity
Resting metabolic rate - more lean mass means your body burns more energy at rest
Functional strength - the ability to carry, lift, climb stairs, and move through daily life without limitation
Long-term healthy aging - preserving muscle mass earlier protects against frailty and loss of independence later
For high performers especially, muscle is often the difference between weight loss that leaves you weaker and weight loss that leaves you stronger.
Protein Intake and Muscle Preservation on GLP-1s
Appetite suppression is one of the core mechanisms of drugs like Ozempic, Wegovy, Mounjaro, and Zepbound — which is exactly what makes hitting adequate protein intake harder while on them. Research suggests a target of 1.2–1.6 grams of protein per kilogram of body weight per day during active weight loss to help preserve lean mass. Some emerging case data suggests that higher protein intake combined with resistance training may help preserve lean mass during GLP-1-associated weight loss.
Practical translation: because your appetite is naturally reduced, every meal needs to count. Anchoring meals around a protein source first - rather than treating it as an afterthought — becomes one of the highest-leverage habits while taking a GLP-1 medication.
Resistance Training and Muscle Preservation on GLP-1s
Protein alone isn't enough, your body needs a reason to hold onto muscle, and resistance training provides that signal. A pooled analysis of six trials in adults with obesity found that resistance training during caloric restriction preserved nearly all lean mass that would otherwise have been lost.
This doesn't require an elite-level lifting program. Case data shows meaningful lean mass preservation in patients doing structured resistance training just 3–5 days a week, using anything from bodyweight movements and resistance bands to dumbbells and standard gym equipment. Consistency matters more than intensity here.
Common Mistakes People Make
Treating appetite suppression as permission to under-eat protein - the drug reduces hunger, not your body's need for amino acids
Skipping resistance training because cardio "feels like it's doing more" - cardio supports cardiovascular health, but it doesn't provide the same muscle-preserving stimulus
Losing weight too fast - aggressive dose escalation without dietary and training support tends to correlate with more lean mass loss
Not tracking body composition, only the scale - the number on the scale doesn't tell you what you actually lost
What to Discuss With Your Healthcare Provider
Everyone's response to GLP-1 therapy is different, and factors like baseline muscle mass, activity level, age, and pre-existing conditions all affect outcomes. Worth raising with your provider:
Your current protein intake and whether it's realistic given appetite changes
Whether a slower titration schedule makes sense for your goals
Any mobility limitations or joint pain, which research suggests may correlate with greater lean mass loss
Whether periodic body composition monitoring (not just weight) makes sense for you
The Bottom Line
Some lean mass loss during GLP-1-driven weight loss is normal and expected, it happens with essentially any significant weight loss method. It is not, on its own, a reason to avoid these medications. But it is a reason to be intentional: adequate protein and consistent resistance training are the two levers with the strongest evidence behind them for shifting the ratio of what you lose back toward fat and away from muscle.
The goal isn't just to weigh less. It's to be leaner, stronger, and more capable at the end of the process than you were at the start.
At ARMA, we believe effective weight management isn't just about the number on the scale. It's about supporting the habits, nutrition, and lifestyle factors that help you feel stronger and perform better throughout the process.
Sources & Further Reading
Neeland IJ, et al. Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? Circulation. 2024.
Prado CM, et al. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. 2024.
Sardeli AV, et al. Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals. Nutrients. 2018.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting, stopping, or making changes to any medication or treatment plan.